CureMeAbroad: Building the Medical Travel Patient Journey

Aditya Oza and Mikhail Bohra brought experience from consumer businesses into a service where the customer may need help long after making a selection. At CureMeAbroad, the product includes the conversation around a hospital, the arrangements around travel and the support around treatment, as well as the website where discovery begins.

Founded in 2025 and based in Pune, India, CureMeAbroad is led by Oza, cofounder and CEO, and Bohra, cofounder and CMO. It helps international patients explore hospitals and doctors, compare options, obtain treatment estimates and coordinate care abroad. Its service is aimed at people trying to understand healthcare options outside their home countries.

The company's recent pre-seed financing gives that operating model more resources, while an independent facilitator certification makes its processes more visible. The company is developing in a category where discovery, patient communication and the work of coordinating independent providers have to improve together.

From concierge beginnings to a discovery platform

CureMeAbroad's account of its origins describes a concierge service launched in the middle of 2025. That history gives its technology a particular context: people were already helping patients navigate hospitals and travel before the platform widened the ways to search and compare. The company's early work was organized around a service relationship.

Oza's founder account of launching Luxora Experiences connects the venture with his experience building EMotorad and Bohra's work at Harbor365. He also describes a family member's difficulty obtaining a consultation in Canada as part of the motivation. That is a founder's account of a specific experience, rather than a measurement of access across an entire healthcare system.

The legal structure and the public brand should also be kept clear. CureMeAbroad's terms identify Luxora Health Care Experiences Private Limited as an operator headquartered in Pune, alongside a registered Curemeabroad Inc. office in Delaware. Those details help connect the earlier venture name with the current service without implying that every registered address is an operating headquarters.

For founders and operators, the interesting progression is the combination of consumer experience and healthcare coordination. A medical-travel service needs to make unfamiliar options understandable, then preserve that understanding as the patient moves into a provider's process. The founders' background gives context for the customer journey; clinical expertise and care remain the responsibility of healthcare professionals.

The product starts with an estimate and continues with people

CureMeAbroad's cost calculator illustrates the discovery workflow. It asks users to select a treatment and country, provide relevant requirements and choose preferences around accommodation and travel assistance. The company describes the resulting estimate as a baseline, with the final quote depending on the medical case, procedure and facility.

That workflow helps explain the company's position between an online directory and a coordination service. A price estimate can help a patient decide which questions to ask next. A useful service then needs people and processes that can connect those questions with the hospital's information, consultations and arrangements around treatment.

Under CureMeAbroad's terms of use, the hospitals and doctors listed on its platform are independent entities. The distinction matters when assessing the business: CureMeAbroad facilitates discovery and coordination, while providers deliver clinical care. Its public AI positioning should be read within those stated platform functions, without assuming autonomous clinical decisions or proven improvements in patient outcomes.

This also makes service quality difficult to express through a directory count alone. The relevant work includes how information passes between a patient and a provider, how an estimate becomes a specific arrangement and how questions are handled as the journey develops. For a company serving patients across borders, a larger choice of hospitals gives those processes more places to operate.

External standards and internal habits

Global Healthcare Accreditation announced CureMeAbroad's Medical Travel Facilitator Certification on September 29, 2026. GHA described an evaluation of the facilitator's practices and documentation. That review provides a process reference for the coordination company, alongside the separate accreditation and clinical responsibilities of the hospitals it works with.

CureMeAbroad is also listed as an active participant in the United Nations Global Compact, with participation beginning May 7, 2026. Participation establishes a corporate commitment within that initiative. It should be understood in that scope rather than as an endorsement of a medical service or its treatment outcomes.

Inside the company, CureMeAbroad describes a specific feedback practice: employees speak first in their one-to-one meetings with managers. A separate company post about onboarding says documentation covers processes and work across countries, while coworkers help new colleagues learn the smaller practical habits. These are the company's descriptions of its culture, rather than an independent assessment of employee experience.

The connection to its operating model is useful. A coordination business depends on information moving between people who have different responsibilities and different views of the same case. Practices that encourage questions and make the work easier to learn can matter to that service model, although their effect on patient experience cannot be established from culture posts alone.

Growth plans put operations beside technology

CureMeAbroad's October 6 funding announcement disclosed a $1.1M pre-seed round led by SteerX Ventures with returning investor AIRA. The company reports a $4.8M annual booking run rate, a booking-volume measure rather than a disclosed revenue figure. Valuation, margins and take rates have not been disclosed in the reviewed announcements.

The announced investment priorities include hospital partnerships, new patient source markets, AI technology and operations and technology teams. These plans make staffing relevant to the company's development, but a dependable current inventory of open roles was not established. Readers following the team can use its official company updates for confirmed opportunities as they emerge.

The operating picture is a company building technology around a service that continues through several organizations. As Oza and Bohra expand CureMeAbroad, new colleagues will need to learn both the documented process and the practical judgment of answering a patient's question. The next version of the platform will arrive alongside the next person learning how that conversation works.